Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVISe: Longitudinal Imaging of Microglial Activation in Alzheimer's Disease
NCT04576793Phase 2Recruiting
- Sponsor
- Columbia University
- Start
- Nov 2020
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]ER176, florquinitau in Alzheimer's disease (AD), sponsored by Columbia University. Started Nov 2020; status: recruiting.
02
Drugs
[11C]ER176florquinitau
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04576793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04576793.